138 related articles for article (PubMed ID: 9687397)
1. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Aug; 42(8):2002-5. PubMed ID: 9687397
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
Isenberg HD; Alperstein P; France K
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):81-6. PubMed ID: 10091030
[TBL] [Abstract][Full Text] [Related]
4. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
[TBL] [Abstract][Full Text] [Related]
5. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.
Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 May; 41(5):1073-6. PubMed ID: 9145872
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Mayer I; Nagy E
J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.
Ribera A; Jurado A; Ruiz J; Marco F; Del Valle O; Mensa J; Chaves J; Hernández G; Jiménez de Anta MT; Vila J
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):123-8. PubMed ID: 11858908
[TBL] [Abstract][Full Text] [Related]
9. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure.
Peterson ML; Hovde LB; Wright DH; Hoang AD; Raddatz JK; Boysen PJ; Rotschafer JC
Antimicrob Agents Chemother; 1999 Sep; 43(9):2251-5. PubMed ID: 10471574
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
12. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Elkhaïli H; Pompei D; Linger L; Kamili N; Monteil H; Jehl F
Pathol Biol (Paris); 1996 May; 44(5):367-73. PubMed ID: 8758478
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Johnson DM; Jones RN; Pfaller MA
J Antimicrob Chemother; 1998 Oct; 42(4):557-9. PubMed ID: 9818765
[No Abstract] [Full Text] [Related]
15. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
Baltch AL; Smith RP; Ritz W
Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
Ristow TA; Peterson LR; Kahn JB
Drugs; 1995; 49 Suppl 2():246-9. PubMed ID: 8549319
[No Abstract] [Full Text] [Related]
17. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin.
Milatovic D; Wallrauch C
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):688-93. PubMed ID: 8894583
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Pendland SL; Messick CR; Jung R
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antibacterial activity of cefpirome in combination with 4 aminoglycosides and 2 fluoroquinolones].
Le Noc P; Croize J; Bryskier A; Le Noc D
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):762-7. PubMed ID: 3141888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
